Skip Navigation


NDT Advance Access originally published online on June 7, 2007
Nephrology Dialysis Transplantation 2007 22(10):2900-2908; doi:10.1093/ndt/gfm316
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/10/2900    most recent
gfm316v2
gfm316v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Artunc, F.
Right arrow Articles by Risler, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Artunc, F.
Right arrow Articles by Risler, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease

Ferruh Artunc and Teut Risler

Department of Internal Medicine IV, Section of Nephrology and Hypertension, Eberhard-Karls-University of Tuebingen, Germany

Correspondence and offprint requests to: Ferruh Artunc, University Hospital Tuebingen, Department of Internal Medicine IV, Section of Nephrology and Hypertension, Otfried-Mueller-Str.10, 72076 Tuebingen, Germany. Email: ferruh.artunc{at}med.uni-tuebingen.de



  Abstract

Background. Renal anaemia is caused by a relative erythropoietin (EPO) deficiency. Due to difficult interpretation of serum EPO concentrations adapted to anaemia and renal function, the diagnostic value of measuring serum EPO concentrations is limited.

Methods. We retrospectively analysed the relationship between haemoglobin and serum EPO concentrations routinely measured in in- and out-patients of our university hospital from 2001–04. Patients under EPO substitution or those with acute renal failure, polycystic kidney disease, renal carcinoma or polycythaemia due to pulmonary disease were excluded. The study population (n = 500) was then stratified according to the presence or absence of chronic kidney disease (CKD) and to the stage if CKD was present. EPO concentrations were expressed in percentiles corrected for the severity of anaemia and based on the EPO response in patients without CKD.

Results. In patients without CKD (n = 167) there was a strong parametric correlation between severity of anaemia and increase in EPO (r = –0.81). Linear regression of the log-transformed EPO values revealed the equation log EPO (mIU/ml) = –0.135 x Hb (g/dl) + 2.821 (r2 = 0.65). With increasing stages of CKD the correlation between haemoglobin and EPO concentrations was gradually attenuated and was completely lost in CKD stage four and five. In anaemic patients with Hb < 11 g/dl, relative EPO deficiency defined as EPO concentrations below the 25th percentile was present in 38%, 67%, 93% and 100% of the patients with CKD stages 1–5, respectively.

Conclusions. Expression of EPO concentrations in percentiles improves the diagnostic value of measuring EPO concentrations for diagnosing relative EPO deficiency and renal anaemia.

Keywords: CKD; diagnostic value; erythropoietin; renal anaemia; response

Received for publication: 14. 3.07
Accepted in revised form: 27. 4.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
E. A. F. de Almeida, I. Alho, F. Marques, C. Thiran, M. P. Bicho, and M. Prata
Haemoglobin and erythropoietin levels in polycystic kidney disease
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 412 - 413.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.